- Home
- GTES vs MIRM Comparison
GTES vs MIRM Comparison
Compare GTES & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GTES | MIRM |
|---|---|---|
| Founded | 1911 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.7B |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | GTES | MIRM |
|---|---|---|
| Price | $25.39 | $91.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 12 |
| Target Price | $28.56 | ★ $115.33 |
| AVG Volume (30 Days) | ★ 2.0M | 631.6K |
| Earning Date | 05-01-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.73 | ★ 74.59 |
| EPS | ★ 0.96 | N/A |
| Revenue | N/A | ★ $19,138,000.00 |
| Revenue This Year | $5.83 | $26.22 |
| Revenue Next Year | $3.95 | $22.04 |
| P/E Ratio | $26.54 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.79 | $40.00 |
| 52 Week High | $28.47 | $109.28 |
Technical Indicators
Market Signals| Indicator | GTES | MIRM |
|---|---|---|
| Relative Strength Index (RSI) | 55.97 | 44.05 |
| Support Level | $24.02 | $85.35 |
| Resistance Level | $26.10 | $98.03 |
| Average True Range (ATR) | 0.83 | 3.22 |
| MACD | 0.14 | -0.49 |
| Stochastic Oscillator | 72.83 | 16.05 |
Price Performance
Historical ComparisonAbout GTES Gates Industrial Corporation plc
Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment. Company operates in USA, United Kingdom, Luxembourg, EMEA, with majority revenue from USA.
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.